Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Carla Uriburu"'
Autor:
Montserrat Rovira, Jordi Vives, Enric Carreras, Carmen Martínez, Anna Gaya, Josep Mensa, Francesc Fernández-Avilés, B. Suárez, Alfons Navarro, Francisco Lozano, Mar Ortega, Emili Montserrat, Ciril Rozman, Josep Maria Roncero, Alvaro Urbano-Ispizua, Miquel Granell, Carla Uriburu
Publikováno v:
Experimental Hematology. 34:1435-1441
Objective The Mannan-binding lectin (MBL) pathway involves recognition of fungal surfaces by MBL and cleavage of C2 and C4 by MBL-associated serine protease (namely, MASP-2). Recent data show that MBL pathway deficiency might result not only from pol
Autor:
Joan Bladé, Rosiñol Laura, María Teresa Cibeira, Emili Montserrat, Carla Uriburu, Olga Salamero, Sebastián Yantorno
Publikováno v:
European Journal of Haematology. 76:405-408
Bortezomib is a potent and selective proteasome inhibitor recently introduced in the treatment of multiple myeloma (MM). This drug produces significant responses in about one-third of patients with relapsed/refractory disease. We first recognized the
Autor:
Carla Uriburu, Montserrat Rovira
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 23:14-18
Las infecciones son la principal causa de muerte en los pacientes neutropenicos, en relacion con el grado y la duracion de la neutropenia, la enfermedad de base y los tratamientos recibidos. Para disminuir estas infecciones se han propuesto estrategi
Autor:
Carla, Uriburu, Montserrat, Rovira
Publikováno v:
Enfermedades infecciosas y microbiologia clinica. 23
Infections are the main cause of death in neutropenic patients and are related to the degree and duration of neutropenia, the underlying disease, and the treatments received. To reduce the number of these infections, prophylactic strategies have been
Autor:
Enric Carreras, B. Suárez, Montserrat Rovira, Anna Guardia, Alvaro Urbano-Ispizua, Mar Ortega, Carmen Martinez, Carme Talarn, Francesc Fernández-Avilés, Francisco Lozano, Miquel Granell, Emili Montserrat, Carla Uriburu
Publikováno v:
Blood. 104:2220-2220
Despite improvement in diagnosis and therapy, invasive fungal infections (IFI) remains one of the most important barriers to the success of allogeneic stem cell transplantation (allo-SCT). Mannan-binding lectin (MBL) gene polymorphisms have been asso